Search results
Moderna Inc (MRNA) Q1 2024 Earnings: Significant Revenue Decline
Guru Focus· 7 hours agoOn May 2, 2024, Moderna Inc (MRNA, Financial) released its 8-K filing, disclosing a challenging first quarter with total revenues of $167 million, a stark decline from $1.9 billion in the same ...
New ‘FLiRT’ Variants Spark Summer COVID Surge Warning
WebMD· 2 days agoWhat’s more, said Ranney, FLiRT also has some concerning features, like changes in the spike protein, which play a role in helping SARS-CoV-2, the virus that causes COVID- ...
Arbutus Biopharma Corp Reports Q1 2024 Earnings: A Detailed Financial Review
GuruFocus.com via Yahoo Finance· 1 hour agoLitigation and Intellectual Property Updates Arbutus continues to defend its intellectual property vigorously, particularly in ongoing litigation with Moderna and Pfizer/BioNTech ...
What to Watch in the Day Ahead - Thursday, May 2
Reuters via Yahoo Finance· 20 hours agoModerna is expected report first-quarter earnings, as it contends with a sharp drop in sales of its COVID-19 vaccine. Investors will ...
This Chinese virologist shared crucial Covid-19 data. Then his research hit hurdles
WKBT La Crosse· 1 day agoZhang Yongzhen’s disclosure of the genome of the virus that causes Covid-19 was a crucial step in...
This Chinese virologist shared crucial Covid-19 data. Then his research hit hurdles
KEYT 3 Santa Barbara· 1 day agoIn the early days of 2020, as science looked for answers to a mysterious viral outbreak in central...
This Chinese virologist shared crucial Covid-19 data. Then his research hit hurdles
CNN.com· 1 day agoZhang Yongzhen’s disclosure of the genome of the virus that causes Covid-19 was a crucial step in...
BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store?
Zacks via Yahoo Finance· 2 days agoOn BioNTech's (BNTX) first-quarter 2024 earnings call, investors' focus is likely to be on the ...
Why I'm Buying This Beaten-Down, High-Yield Dividend Stock Hand Over Fist
Motley Fool via Yahoo Finance· 2 days ago* Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance...
Arbutus Biopharma Corp Reports Q1 2024 Earnings: A Detailed Fina
Guru Focus· 2 hours agoRevenue: Reported at $1.5 million for Q1 2024, a significant decrease from $6.7 million in Q1 2023, falling short of the estimated $2.15 million.Net Loss: Reco